Pharmacogenomics-Supported Psychotropic Prescribing Trial
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Manitoba
About this trial
Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.
Eligibility criteria
Qualifiers
Aged 18 years or older
The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated
The treating clinician thinks PGx testing can benefit and refers the patient to the study
Disqualifiers
Unwillingness to donate saliva samples for genetic analysis
History of liver or bone marrow (hematopoietic cell) transplantation
PGx testing results are already available
No personal health identification number (PHIN) is available
Trial design
Treatments tested in this trial
- Pharmacogenetic Testing
Treatment groups
200 Participants
are divided into 1 treatment groupLocations
2Shared Health FacilitiesR3C 3H8, WinnipegManitoba, Canada
University of Manitoba College of PharmacyR3E 0T5, WinnipegManitoba, Canada
Sponsors and collaborators
University of Manitoba
Lead sponsor
University of Calgary
Collaborator
Shared Health Manitoba
Collaborator
Winnipeg Regional Health Authority
Collaborator
Health Sciences Centre, Winnipeg, Manitoba
Collaborator
Source ClinicalTrials.gov